Special Issue "Breakthroughs in Antimicrobial Peptides"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 May 2019) | Viewed by 13449
Special Issues, Collections and Topics in MDPI journals
Special Issue in Molecules: Bioactive Peptides—From Therapy to Nutrition
Special Issue in Molecules: Recent Contributions of Female Scientists to the Advancement of Medicinal Chemistry
Special Issue in Molecules: The Emerging Role of Antimicrobial Peptides in the Agro-Food Sector
Antimicrobial peptides (AMPs) are continuously attracting attention as a challenging opportunity for advanced medical applications. The rapid worldwide development of resistance to conventional antibiotics makes it imperative to allocate efforts to bring AMPs with advanced properties into clinical use. In fact, antibiotic resistance is a priority concern, and the technological development of new materials with antimicrobial properties provides a breakthrough for the discovery of new molecules for therapeutic use.
This Special Issue of Pharmaceutics focuses on new strategies and approaches to AMP-based systems intended for antimicrobial therapies, which could also be combined with anti-cancer therapies. We welcome articles concerning all aspects of AMP-based molecules designed for advanced therapy. Especially, studies on the relationships between biophysical features and activities, new materials, original synthetic approaches, innovative formulation and delivery strategies are welcome for this Special Issue. Articles illustrating current and future trends in the development of AMP therapeutics spanning a multitude of disciplines including chemistry, physics, biology, pharmaceutical materials science, and contributing to the design of highly active molecules are highly encouraged.
Prof. Stefania Galdiero
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.